AMRN

Amarin Corporation PLC

Amarin Corporation PLC is a biopharmaceutical company that specializes in developing and commercializing therapeutics for cardiovascular diseases. Its lead product, Vascepa, is a prescription omega-3 fatty acid medication approved by the US FDA for severe hypertriglyceridemia. Amarin is also conducting clinical trials to evaluate Vascepa's potential in reducing cardiovascular events in patients with elevated triglyceride levels. The company is dedicated to advancing cardiovascular disease science and improving patient outcomes through innovative research and development. Headquartered in Dublin, Ireland, Amarin operates in the US and other countries.

Instrument specification in OANDA

Name
Currency
Symbol
Minimum order value
Ticker
Trading hours
Type
Hours of accepting orders
ISIN

Start trading now with fast account opening.

Sign-up now to trade the most active markets

Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
Scroll to top